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Background
● Bipolar Disorder (BPD), which affects 3% of the world’s population, is 
characterized by manic and depressive episodes, along with abnormal sleep-wake 
patterns (4).
● Elevated levels of homocysteine and its metabolite homocysteic acid (HCA) have 
been associated with schizophrenia, depression, and bipolar disorder (2).
● An animal model for BPD with face, construct, and predictive validity has yet to be 
established (1). 
● The working hypothesis was that the administration of HCA to rat pups would 
result in an animal model with mixed mood state behaviors.
● Prepubescent emergence of manic and depressive-like behaviors have not been 
previously examined (1), and may illuminate important developmental markers for 
early recognition of BPD.
● In the present study, behavior and circadian rhythms were analyzed in rats injected 
with either HCA or saline solution from postnatal days P3-P21.
● Rats were tested in the following apparatuses:
○ Open field test (OFT) for locomotion and anxiety-like behaviors
○ Elevated plus maze (EPM) for risk-taking behaviors
○ Saccharin preference test (SPT) for reward-seeking behaviors
● Behaviors were measured pre- and post-puberty to assess the effects of HCA on the 
emergence of BPD-like behaviors across development.
● BPD patients present abnormalities in circadian rhythmicity and sleeping patterns. 
HCA-treated rats exhibit disrupted CLOCK expression in the prefrontal cortex (3).
○ Circadian analyses of singly-housed rats using infrared sensors were used to 
examine any treatment-specific differences in  activity levels and circadian 
rhythmicity.
● We predicted that HCA treated rats would exhibit significant abnormalities in 




● From P3-P21, Sprague Dawley rat pups received daily intraperitoneal injections of 
HCA (0.8 mmol/kg) or saline solution (0.8 mmol/kg)
  
● The following behavioral tests were performed to assess BPD-like behaviors. 
Prepubescent behavioral tests were performed prior to P42, and post-pubescent 
behavioral tests were performed after P42.
● Open Field Test (OFT); Exploration of apparatus for 5 minutes
● Elevated Plus Maze (EPM): Exploration of apparatus for 5 minutes
● Saccharin Preference Test (SPT) for 6 days
● Days 1-2: Both bottles contain water
● Days 3-4: Choice between water and 0.033% saccharin
● Days 5-6: Choice between water and 0.066% saccharin
● After P42, HCA and saline female rats were individually housed in cages with overhead    
Infrared Motion Detectors.  Activity was counted in one  minute intervals.  
● Rats were placed in 12:12 light-dark conditions (LD) for 3 weeks 
● Placed under constant darkness conditions (DD) for 2 weeks
● Placed under constant darkness conditions (DD) + Lithium for 4 weeks
○ Lithium: 2 g/1000 g of food
● Return to 12:12 light-dark conditions for 2 weeks
● 2 hour light pulse (LP) administered, from Zeitgeber time (ZT) 13-15 during 12:12 LD
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The effects of HCA treatment on circadian function and post-pubescent 
behavior in rats align with a mixed mood state, similar to symptoms seen in 
Bipolar Disorder patients. Thus, providing face validity for the HCA animal 
model of Bipolar Disorder. 
● Prior to puberty, mixed mood state behaviors were not observed in HCA-treated rats.
● After puberty, HCA-treated rats displayed an increase in risk-taking behaviors in the 
Elevated Plus Maze (EPM).
● BPD patients in manic episodes present increases in risk-taking and exploratory 
behavior (1).
● On days 4 and 6 of the post-puberty saccharin preference test, HCA-treated rats 
consumed a significantly lower proportion of 0.033% and 0.066% saccharin solution 
respectively compared to Saline-treated rats, indicating anhedonic-like behavior.
● During depressive episodes, BPD patients present decreases in reward-seeking 
behaviors or anhedonia (1).
● HCA-treated female rats display a lower circadian amplitude and period compared to 
Saline-treated rats during constant darkness (DD), indicating an effect of 
HCA-treatment on the circadian clock. Lithium treatment reversed this phenotype.
● BPD patients often present with abnormalities in circadian rhythmicity and sleeping 
patterns (3).
● HCA-treated female rats present a decrease and delay in the suppression of activity as 
an acute response to light during a 2-hour light pulse at ZT13 during 12:12 light/dark.
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Figure 7. Representative Actograms. The actograms present 3 weeks of 12:12 light/dark (LD, 
green line), 2 weeks of constant darkness (DD, blue line), and 4 weeks of lithium treatment in DD 
(yellow line) for a Saline female and HCA female.
Figure 8. Circadian Period Between Treatment Groups. Female HCA-treated rats had 
a significantly shorter circadian period in constant darkness conditions than saline controls 
(t34 = -6.777 , p < 0.001), and saline + lithium along with HCA + lithium rats had a 
significantly longer circadian period than without lithium (ts23 = 3.212 , ps < 0.005).
Figure 9. Amplitude of Circadian Rhythm. HCA-treated females had a significantly lower 
circadian amplitude when compared to the saline group (t34 = -4.524 p < .001). Amplitude 
measurements were averaged over 7 days of constant darkness conditions using ClockLab software.
Figure 10. Change in Activity from Baseline Day During 2 Hour Light Pulse. HCA-treated 
female rats exhibited a significantly dampened response during the 1st hour of a 2 hour light pulse 
during 12:12 LD beginning at ZT13 as compared to Saline-treated rats (t34 = 3.92, p <.001).
Figure 5. 0.033 M Saccharine Consumption. Consumption of 0.033 M saccharine was significantly 
affected by HCA-treatment post-puberty (t66 = 2.065, p < .05) but not pre-puberty (t66 = 1.699, p = .094).
Figure 6. 0.066 M Saccharine Consumption. Consumption of 0.066 M saccharine was significantly 
affected by HCA-treatment post-puberty (t66 = 2.266, p < .05) but not pre-puberty (t66 = 1.391, p = .169).
Figure 1. Distance in center zone of Open Field Test. The distance in the center zone of the OFT was not 
affected by HCA-treatment either pre-puberty (t66 = .462, p = .645) or post-puberty (t66 = -.264, p = .793).
Figure 2. Time in center zone of Open Field Test. The time in the center zone of the OFT was not 
affected by HCA-treatment either pre-puberty (t66 = .530, p = .598) or post-puberty (t66 = .450, p = .654).
Figure 3. Distance in open arms of Elevated Plus Maze. Distance in open arms of EPM was significantly 
affected by HCA-treatment post-puberty (t66 = -2.081, p < .05) but not pre-puberty (t66 = -1.453, p = .151).
Figure 4. Time in open arms of Elevated Plus Maze. Time in open arms of EPM was significantly 
affected by HCA-treatment post-puberty (t66 = -2.543, p < .05) but not pre-puberty (t66 = -1.435, p = .156).
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